Home /

Meet the Management Team

Stephen Barr

Stephen Barr

President & Managing Director, Almac Discovery

Stephen is a member of the Almac Group Executive Management and President and Managing Director of both Almac Discovery and Almac Sciences. He was instrumental in establishing Almac Discovery and has had overall responsibility for strategic, financial and operational leadership ever since.

Click to Read More
Graham Cotton

Graham Cotton

Head of Protein Therapeutics

Graham joined Almac from the acquisition of Albachem and subsequently joined Almac Discovery to bring expertise in peptide and protein chemistry. Graham has responsibility for the technical management of Discovery’s Protein Drug Conjugate key research focus within Almac Discovery and was important in the discovery of the peptide clinical candidate, ALM201.

Click to Read More
Aaron Cranston

Aaron Cranston

Head of Translational Research

Aaron joined Almac Discovery in 2016 and has responsibility for translational research activities including key external research collaborations. Aaron has over 20 years of experience in preclinical oncology and left Mission Therapeutics, where he was Head of Pharmacology for the deubiquitylating enzyme (DUB) specialist, to join Discovery. Aaron has also previously worked for PRECOS, a specialist oncology CRO and KuDOS Pharmaceuticals (acquired by AstraZeneca). At KuDOS, he made notable contributions to the PARP inhibitor programme which led to olaparib (Lynparza®), now a first-in-class marketed treatment for BRCA-mutant ovarian cancer.

Click to Read More
Lisa Goddard

Lisa Goddard

Head of Project Management

Lisa joined Almac Discovery in 2016 and has responsibility for the project management of preclinical and clinical programmes. She has 10 years of mainly oncology experience gained across both drug development and stratified medicine.

Click to Read More
Tim Harrison

Tim Harrison

Vice President Discovery Chemistry

Tim joined Almac Sciences in 2006 as Vice President of Research and Development before moving to Almac Discovery on its establishment in 2008: an initiative he had played a key role in planning and championing. He now has responsibility for all R&D activities and for coordinating the relationship with Queen’s University which, most recently, is via the Centre for Precision Therapeutics.

Click to Read More
Xavier Jacq

Xavier Jacq

Vice President, Biology

Xavier joined Almac Discovery in 2018 and is leading the biology team for the company’s small molecule discovery. He has over 18 years of industry experience and a track record in early stage discovery and development for highly innovative oncology and CNS drug target classes.

Click to Read More
Colin O’Dowd

Colin O’Dowd

Head of Medicinal Chemistry

Colin manages the medicinal chemistry, ADMET and CADD groups within Almac Discovery bringing to bear his experience in chemistry contract research from his 9 year tenure in Almac Sciences.

Click to Read More
Alan Lamont

Alan Lamont

VP Business Development and Licensing

Alan joined Almac Discovery in October 2019 and has responsibility for all commercial activities, including the evaluation, structuring, negotiation and due diligence of BD and Licensing opportunities, and providing commercial input into research and discovery strategy as part of the Discovery senior management team.

Click to Read More
This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies